Skip to main navigation Skip to search Skip to main content

Weekly dihydroartemisinin–piperaquine versus monthly sulfadoxine–pyrimethamine for malaria chemoprevention in children with sickle cell anaemia in Uganda and Malawi (CHEMCHA): a randomised, double-blind, placebo-controlled trial

  • Richard Idro
  • , Thandile Nkosi-Gondwe
  • , Robert Opoka
  • , John M. Ssenkusu
  • , Kalibbala Dennis
  • , Lufina Tsirizani
  • , Pamela Akun
  • , Joseph Rujumba
  • , Winnie Nambatya
  • , Carol Kamya
  • , Nomsa Phiri
  • , Kirikumwino Joanita
  • , Ronald Komata
  • , Mailosi Innussa
  • , Emmanuel Tenywa
  • , Chandy C. John
  • , Joel Tarning
  • , Paolo Denti
  • , Roeland E. Wasmann
  • , Feiko O. ter Kuile
  • Bjarne Robberstad, Kamija S. Phiri

Research output: Contribution to journalArticlepeer-review

6 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Weekly dihydroartemisinin–piperaquine versus monthly sulfadoxine–pyrimethamine for malaria chemoprevention in children with sickle cell anaemia in Uganda and Malawi (CHEMCHA): a randomised, double-blind, placebo-controlled trial'. Together they form a unique fingerprint.
Sort by

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science